↓ Skip to main content

PLOS

A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection

Overview of attention for article published in PLOS ONE, May 2013
Altmetric Badge

Citations

dimensions_citation
209 Dimensions

Readers on

mendeley
168 Mendeley